1. Complement and Fungal Dysbiosis as Prognostic Markers and Potential Targets in PDAC Treatment
   Cornelia Speth et al, 2022, Current Oncology CrossRef
2. Prediagnostic Serum Biomarkers as Early Detection Tools for Pancreatic Cancer in a Large Prospective Cohort Study
   Brian M. Nolen et al, 2014, PLoS ONE CrossRef
3. Blood-Based Multiomics-Guided Detection of a Precancerous Pancreatic Tumor
   Mohammad A. Anwar et al, 2024, OMICS: A Journal of Integrative Biology CrossRef
4. Complement System: Promoter or Suppressor of Cancer Progression?
   Margot Revel et al, 2020, Antibodies CrossRef
5. Apolipoproteins: New players in cancers
   Yingcheng He et al, 2022, Frontiers in Pharmacology CrossRef
6. Biomarkers for early diagnosis of pancreatic cancer
   Claire Jenkinson et al, 2015, Expert Review of Gastroenterology & Hepatology CrossRef
7. Context-dependent roles of complement in cancer
   Lubka T. Roumenina et al, 2019, Nature Reviews Cancer CrossRef
8. Inhibition of Lung Tumor Development in ApoE Knockout Mice via Enhancement of TREM-1 Dependent NK Cell Cytotoxicity
   Yong Sun Lee et al, 2019, Frontiers in Immunology CrossRef
9. Intratumour microbiome of pancreatic cancer
   Shi-Wei Guan et al, 2023, World Journal of Gastrointestinal Oncology CrossRef
10. Upregulation of C1-inhibitor in pancreatic cancer
    Kurt Osther et al, 2019, Oncotarget CrossRef
11. Prognostic Model and Tumor Immune Microenvironment Analysis of Complement-Related Genes in Gastric Cancer
    Xianhua Gu et al, 2023, Journal of Inflammation Research CrossRef
12. Protein Arginine Methylation Patterns in Plasma Small Extracellular Vesicles Are Altered in Patients with Early-Stage Pancreatic Ductal Adenocarcinoma
    Kritisha Bhandari et al, 2024, Cancers CrossRef
13. Effects of the subtypes of apolipoprotein E on immune inhibition and prognosis in patients with Hepatocellular Carcinoma
    Bowen Gao et al, 2024, Journal of Cancer Research and Clinical Oncology CrossRef
14. Plasma levels of apolipoprotein E, APOE genotype, and all-cause and cause-specific mortality in 105 949 individuals from a white general population cohort
    Katrine L Rasmussen et al, 2019, European Heart Journal CrossRef
15. Advancing serum peptidomic profiling by data-independent acquisition for clear-cell renal cell carcinoma detection and biomarker discovery
    Lin Lin et al, 2020, Journal of Proteomics CrossRef
16. Evasion and interactions of the humoral innate immune response in pathogen invasion, autoimmune disease, and cancer
    Trisha A. Rettig et al, 2015, Clinical Immunology CrossRef
17. Identification of Carcinogenesis and Tumor Progression Processes in Pancreatic Ductal Adenocarcinoma Using High-Throughput Proteomics
    Lucía Trilla-Fuertes et al, 2022, Cancers CrossRef
18. Chronic Pancreatitis and the Development of Pancreatic Cancer
    Hemanth K. Kandikattu et al, 2020, Endocrine, Metabolic & Immune Disorders - Drug Targets CrossRef
19. FN1 encoding fibronectin as a pivotal signaling gene for therapeutic intervention against pancreatic cancer
    Gayathri Ashok et al, 2022, Molecular Genetics and Genomics CrossRef
20. Label-Free Quantitative Proteomics Unravels Carboxypeptidases as the Novel Biomarker in Pancreatic Ductal Adenocarcinoma
    Yang Song et al, 2018, Translational Oncology CrossRef
21. Neutrophil‐lymphocyte and platelet‐lymphocyte ratio as predictors of disease specific survival after resection of adrenocortical carcinoma
    Fabio Bagante et al, 2015, Journal of Surgical Oncology CrossRef
22. Reduced expression of innate immunity-related genes in lymph node metastases of luminal breast cancer patients
    Marta Popeda et al, 2021, Scientific Reports CrossRef
23. The role of quantitative mass spectrometry in the discovery of pancreatic cancer biomarkers for translational science
    Daniel Ansari et al, 2014, Journal of Translational Medicine CrossRef
24. Plasma protein profiling in a stage defined pancreatic cancer cohort – Implications for early diagnosis
    Anna Sandström Gerdtsson et al, 2016, Molecular Oncology CrossRef
25. Secretomes are a potential source of molecular targets for cancer therapies and indicate that APOE is a candidate biomarker for lung adenocarcinoma metastasis
    Zan Liu et al, 2014, Molecular Biology Reports CrossRef
26. Elevated serum apolipoprotein E is associated with metastasis and poor prognosis of non-small cell lung cancer
    Jinmei Luo et al, 2016, Tumor Biology CrossRef
27. Complement in Pancreatic Disease—Perpetrator or Savior?
    Lucas Bettac et al, 2017, Frontiers in Immunology CrossRef